HGF and pituitary adenocarcinoma: MET is a transmembrane tyrosine kinase identified as a high-affinity receptor for hepatocyte growth factor (HGF), and both MET and HGF were demonstrated to be expressed in PTCa [42], and consequently promote progression and secondary metastasis [44].